November 23rd 2024
A systematic review has found a potential link between edentulism and sleep apnea risk, although the authors said differences in study designs prohibited a meta-analysis.
What We're Reading: Drug Pricing Debate; Judge Rules Against Walgreens; Predicting TBI Outcomes
August 11th 2022Policy observers and industry stakeholders debate the possible spillover effects of Medicare drug pricing reform in the employer-based insurance market; a California federal judge rules Walgreens could be held liable for not investigating suspicious orders of opioids in San Francisco; a blood test performed the day of a traumatic brain injury (TBI) can predict which patients may die and who may survive with a disability.
Read More
Race, Insurance Type Among Predictors of Depressive Symptoms in Atopic Dermatitis
August 10th 2022Most patients with atopic dermatitis had flunctuating levels of depressive symptoms, with having public or no insurance, more severe itch, and skin pain cited as additional predictors of adverse mental health outcomes.
Read More
What We’re Reading: Alzheimer Drug Setback; Rural Health Care Investment; Monkeypox Drug Delivery
August 10th 2022Acadia Pharmaceuticals’ pimavanserin (Nuplazid) was not extended by the FDA to include Alzheimer-related psychosis; HHS/Health Resources and Service Administration vow to strengthen rural health care; a new deal has the United States paying $26 million for Siga Technologies’ Tpoxx.
Read More
Heart Failure Prognosis Not Improved by Risk Score Prediction
August 10th 2022The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.
Read More
Reducing Health Care Disparities Starts at the Top, Says Dr Sachin Jain
August 10th 2022In this episode of Managed Care Cast, we speak with Sachin Jain, MD, MBA, SCAN Group and Health Plan's president and CEO, about how the organization made 10% of senior managers’ annual bonuses dependent on how well the gap in medication adherence among diverse populations was reduced.
Listen
Hepatitis C Reinfection Rates Low After Successful Treatment in People Who Inject Drugs
August 8th 2022Treatment of hepatitis C virus (HCV) with direct-acting antiviral medications was associated with low HCV reinfection rates among patients who inject drugs, although risk for reinfection was highest in the first 24 weeks of treatment and among those with ongoing injecting drug use.
Read More
Budget Bill Allowing Medicare to Negotiate Drug Prices Heads to House
August 8th 2022HR 5376, or the Inflation Reduction Act, is most significant piece of legislation affecting federal health policy since the passage of the Affordable Care Act in 2010; for Medicare beneficiaries, it caps insulin at $35 a month and includes other pricing reforms.
Read More
Advocate Addresses Factors Physicians Should Consider in Managing Hidradenitis Suppurativa
August 5th 2022Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), spoke on the need for awareness among physicians and patients on the clinical features of HS in regard to both physical and psychosocial burdens.
Watch
Preappointment Surveys and Reminder Calls to Improve Show Rate
Patients who completed a preappointment survey were significantly more likely to attend their clinic appointment than noncompleters and spent significantly less time in their appointment.
Read More
Three CAR T-Cell Trials, 2 Outcomes, for Second-line LBCL Therapy
August 4th 2022Both the ZUMA-7 trial for axicabtagene ciloleucel—approved for second-line treatment earlier this year—and the TRANSFORM trial for lisocabtagene maraleucel showed significant improvement over standard of care for large B cell lymphoma (LBCL), while the BELINDA trial for tisagenlecleucel did not.
Read More
Phase 3 Study: Zanubrutinib Improves PFS Over Chemoimmunotherapy in Untreated CLL, SLL
August 4th 2022The findings, coming from the phase 3 SEQUOIA study, found that the next-generation, selective Bruton tyrosine kinase inhibitor had superior efficacy versus chemoimmunotherapy and demonstrated an acceptable safety profile among 600 older patients with comorbidities.
Read More
Cardiologists Must “Get Into the Game” With Novel Agents in Patients With Diabetes
August 3rd 2022During the 2022 Congress of the American Society for Preventive Cardiology (ASPC), held in Louisville, Kentucky, Erin D. Michos, MD, MHS, of Johns Hopkins, and Pam R. Taub, MD, of UC San Diego Health, discussed how treatment of diabetes requires going beyond glucose-lowering therapies and including newer medications that offer cardiovascular benefits.
Read More
Tools Physical Therapists Can Use to Create Plans for Safe Aging in Place
August 3rd 2022Comprehensive geriatric assessments are designed to keep frail older adults healthy and out of hospitals and nursing homes; a recent article described the the components that make up an assessment and how they can apply to a physiotherapy evaluation.
Read More
Asian Patients With Psoriasis Receive Shortest Visits With Dermatologists
August 3rd 2022Dermatologists spend less time face-to-face with Asian patients with psoriasis compared with patients of other races and ethnicities, despite Asian patients frequently experiencing more severe cases of psoriasis.
Read More
Kansas voters rejected an anti-abortion measure while the Department of Justice sued Idaho to protect abortion access; the US uninsured rate hit a record low of 8% at the start of 2022; the Senate passed an expansion of veteran health care, sending it to President Biden’s desk.
Read More